Cooley advised 5AM Ventures on the deal. 5AM Ventures, a venture capital firm focused on building next-generation life sciences companies, announced the close of 5AM Ventures...
5AM Ventures’ $750 Million Fund Closing
GlycoEra’s CHF 45 Million Series A Financing Round
Vischer advised GlycoEra AG on the deal. Walder Wyss advised 5AM Ventures, Roche Venture Fund and Sofinnova Partners as lead investors. GlycoEra AG has closed CHF...
Camp4 Therapeutics’ $45 Million Series B Financing Round
Choate represented 5AM Ventures in the transaction. Camp4 Therapeutics closed a $45M Series B financing round, led by 5AM Ventures. 5AM Ventures and Northpond Ventures joined...